Stock Market News
Liberum upgrades UDG Healthcare to 'buy'
Expectations for UDG Healthcare's earnings in 2018 and 2019 are too gloomy, Liberum said as the broker upgraded the provider of services to the healthcare industry to 'buy'.
The FTSE 250 company's guidance is for organic revenue growth of 0-3% in 2018 and analysts' consensus is at the bottom of the range, but UDG will do better, Liberum analyst Graham Doyle wrote in a note. He upped his rating from 'hold' and maintained a price target of 884p a share.
In further evidence of market pessimism, UDG shares have lost more than a fifth of their value since November and the percentage of analysts with a 'buy' rating has dropped from 90% to 40% in the past year, Doyle said. Now is the time to take advantage of an "attractive entry point" for the shares, he said.
Doyle wrote: "Consensus earnings expectations are too pessimistic, lying at the bottom-end of a 2018 guidance range (implying zero organic growth) that we expect management to beat. With UDG set to enter another upgrade cycle and [with] the shares off 22% from their November peak, we upgrade to 'buy'."
Analysts are also underestimating UDG's potential performance in 2019 after 18 months of underperformance. Organic growth will be 4% in 2018 and 13% in 2019 when UDG will regain its "darling status" with investors, he said. UDG has the financial strength to make acquisitions that would add to earnings, he added.
At 1305 GMT, the shares were up 4.6% to 776p.
The FTSE 250 company's guidance is for organic revenue growth of 0-3% in 2018 and analysts' consensus is at the bottom of the range, but UDG will do better, Liberum analyst Graham Doyle wrote in a note. He upped his rating from 'hold' and maintained a price target of 884p a share.
In further evidence of market pessimism, UDG shares have lost more than a fifth of their value since November and the percentage of analysts with a 'buy' rating has dropped from 90% to 40% in the past year, Doyle said. Now is the time to take advantage of an "attractive entry point" for the shares, he said.
Doyle wrote: "Consensus earnings expectations are too pessimistic, lying at the bottom-end of a 2018 guidance range (implying zero organic growth) that we expect management to beat. With UDG set to enter another upgrade cycle and [with] the shares off 22% from their November peak, we upgrade to 'buy'."
Analysts are also underestimating UDG's potential performance in 2019 after 18 months of underperformance. Organic growth will be 4% in 2018 and 13% in 2019 when UDG will regain its "darling status" with investors, he said. UDG has the financial strength to make acquisitions that would add to earnings, he added.
At 1305 GMT, the shares were up 4.6% to 776p.
Related share prices |
---|
UDG Healthcare Public Limited Company (UDG) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price